| Income Statement |
| Total Revenue | 46.52M |
|
| Revenues (USD) | 46.52M |
| Cost of Revenue | 36.66M |
| Gross Profit | 9.86M |
| Operating Expenses | 8.92M |
| Research and Development Expense | 788.00K |
| Selling, General and Administrative Expense | 4.99M |
| Operating Income | 940.00K |
| Interest Expense | 516.00K |
| Income Tax Expense | 86.00K |
| Net Income | 337.00K |
| Net Income Common Stock | 337.00K |
| Net Income Common Stock (USD) | 337.00K |
| Consolidated Income | 337.00K |
| Earning Before Interest & Taxes (EBIT) | 939.00K |
| Earning Before Interest & Taxes (USD) | 939.00K |
| Weighted Average Shares | 16.81M |
| Weighted Average Shares Diluted | 17.06M |
| Balance Sheet |
| Cash and Equivalents | 10.91M |
| Cash and Equivalents (USD) | 10.91M |
| Trade and Non-Trade Receivables | 11.67M |
| Property, Plant & Equipment Net | 3.58M |
| Total Assets | 71.18M |
| Total Debt | 25.48M |
| Total Liabilities | 50.40M |
| Accumulated Retained Earnings (Deficit) | -20.26M |
| Accumulated Other Comprehensive Income | 37.00K |
| Shareholders Equity | 20.78M |
| Shareholders Equity (USD) | 20.78M |
| Total Debt (USD) | 25.48M |
| Goodwill and Intangible Assets | 40.34M |
| Trade and Non-Trade Payables | 24.93M |
| Cash Flow |
| Depreciation, Amortization & Accretion | -21.00K |
| Net Cash Flow from Financing | -720.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 383.00K |
| Capital Expenditure | -15.00K |
| Issuance (Repayment) of Debt Securities | -507.00K |
| Net Cash Flow from Investing | -15.00K |
| Net Cash Flow from Operations | 1.12M |
| Share Based Compensation | 164.00K |